(Q37668243)

21 August 2017

1 reference

title

A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors (English)

1 reference

21 August 2017

R W Jones

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

International Journal of Geriatric Psychiatry

21 August 2017

published in

1 reference

21 August 2017

volume

25

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

547-553

1 reference

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease

21 August 2017

cites work

1 reference

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients.

21 January 2018

1 reference

Donepezil preserves cognition and global function in patients with severe Alzheimer disease

21 January 2018

1 reference

7 January 2021

1 reference

7 January 2021

Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials

1 reference

7 January 2021

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

1 reference

7 January 2021

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

1 reference

7 January 2021

Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.

1 reference

7 January 2021

Donepezil for the treatment of agitation in Alzheimer's disease

1 reference

7 January 2021

Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease.

1 reference

7 January 2021

Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.

1 reference

7 January 2021

Antipsychotic Therapy and Short-term Serious Events in Older Adults With Dementia

1 reference

7 January 2021

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

1 reference

7 January 2021

Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence

1 reference

7 January 2021

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.2384

1 reference

21 August 2017

1 reference